Skip to content

800.850.4306

  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe

Tag: Biopharma

IBTROZI™ (Taletrectinib), FDA-Approved Treatment, Available at Biologics by McKesson

Cary, N.C. , June 11, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

Improving Oncology Patient Outcomes: The Future of Risk-Based Care

Ela Lourido, Biologics VP Biopharma

Research shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes.

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2024 McKesson Corporation. All Rights Reserved.